| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |